Course Outline
Click on the links below to preview selected pages from this course.
- Introduction
- Definition of Thrombocytopenia
- Signs Associated with Thrombocytopenia
- Which of the following is a clinical sign that is associated with thrombocytopenia?
- Conditions Causing Increased Destruction and Consumption of Platelets
- Increased Platelet Destruction
- Immune Thrombocytopenic Purpura
- Drug-Induced Thrombocytopenia
- Drug-Induced Thrombocytopenia
- Pathophysiology of Heparin-Induced Thrombocytopenia
- Additional Complications Related to Heparin-Induced Thrombocytopenia
- True or False: When heparin-induced thrombocytopenia occurs, the platelet count noticeably decreases immediately after heparin treatment begins.
- Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome
- Disseminated Intravascular Coagulation
- Conditions Causing Decreased Platelet Production
- Impaired Platelet Production Disorders
- True or False: Patients undergoing chemotherapy treatments will have deficiencies in platelet numbers as well as red and white blood cells.
- With which of these conditions or procedures may there be an increased number of megakaryocytes in the bone marrow but a decreased number of circulati...
- Other Causes of Thrombocytopenia
- Variables Causing False Thrombocytopenia
- References
Additional Information
Level of Instruction: Intermediate
Intended Audience: Medical laboratory scientists, medical
laboratory technicians, laboratory supervisors, and laboratory managers. This
course is also appropriate for MLS and MLT students and pathology residents.
Author Information: Betty Ciesla, MS, MLS(ASCP)SH, is a faculty member at Morgan State University in Maryland. She holds an MS degree in Biomedical Communication. She has presented at national workshops in Hematology and Coagulation, authored several book chapters and articles on topics in Hematology, and served on the ASCP’s Tech Sample Committee, Education Program Committee, and, most recently, the Hematology Examination Committee.
The author has no
conflict of interest to disclose.
Reviewer Information:
Laurie Bjerklie, MA, MLS(ASCP)CM, is
a Lead Education Developer. She earned a B.S. in Medical Laboratory Science
from the University of North Dakota and an M.A. in Curriculum and Instruction
from Saint Xavier University. She has over 15 years of experience in higher
education and has held program director and faculty positions in both MLT and
MLS programs.
Barbara Caldwell, MS, MLS(ASCP)SH, is the administrative director of clinical laboratory services at Montgomery General Hospital in Olney, Maryland. She is also an experienced educator, having served as a Clinical Assistant Professor at the University of Maryland School of Medicine in the Department of Medical and Research Technology. Ms. Caldwell holds an MS degree from the University of Maryland School of Medicine. She has authored numerous textbook chapters, articles, and abstracts related to topics in Hematology.
